FGF19 and hepatocellular carcinoma: In HCC, overexpression of FGF19 not only promotes EMT by activating the GSK3β/β-catenin and STAT3 pathways (Zhao et al., 2016b) but it also shields HCC cells against endoplasmic reticulum (ER) stress.